<![CDATA[GE Healthcare 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=22695>Fri, 24 Apr 2026 22:35:19 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents]]>https://www.newswire.co.kr/newsRead.php?no=1033096Fri, 24 Apr 2026 13:51:01 +0900<![CDATA[GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners]]>https://www.newswire.co.kr/newsRead.php?no=1025633Thu, 18 Dec 2025 11:45:00 +0900<![CDATA[GE 헬스케어, 인도네시아 보건부와 300대 이상의 첨단 CT 스캐너 공급 계약… 양질의 의료 접근성 확대]]>https://www.newswire.co.kr/newsRead.php?no=1025634Thu, 18 Dec 2025 11:45:00 +0900<![CDATA[GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan]]>https://www.newswire.co.kr/newsRead.php?no=1008486Mon, 31 Mar 2025 15:40:00 +0900<![CDATA[GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand]]>https://www.newswire.co.kr/newsRead.php?no=1005115Fri, 31 Jan 2025 17:24:07 +0900<![CDATA[GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical]]>https://www.newswire.co.kr/newsRead.php?no=1001988Mon, 02 Dec 2024 14:15:00 +0900<![CDATA[GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent]]>https://www.newswire.co.kr/newsRead.php?no=998153Tue, 08 Oct 2024 08:37:08 +0900<![CDATA[GE HealthCare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies]]>https://www.newswire.co.kr/newsRead.php?no=977897Fri, 03 Nov 2023 09:10:06 +0900<![CDATA[SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers]]>https://www.newswire.co.kr/newsRead.php?no=976153Thu, 12 Oct 2023 13:31:05 +0900<![CDATA[First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies]]>https://www.newswire.co.kr/newsRead.php?no=968845Thu, 15 Jun 2023 15:38:57 +0900<![CDATA[GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent]]>https://www.newswire.co.kr/newsRead.php?no=962448Thu, 02 Mar 2023 11:15:00 +0900<![CDATA[GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity]]>https://www.newswire.co.kr/newsRead.php?no=956004Fri, 18 Nov 2022 14:30:00 +0900<![CDATA[GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media]]>https://www.newswire.co.kr/newsRead.php?no=953370Fri, 14 Oct 2022 09:35:00 +0900<![CDATA[GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease]]>https://www.newswire.co.kr/newsRead.php?no=951225Wed, 14 Sep 2022 13:55:00 +0900<![CDATA[GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment]]>https://www.newswire.co.kr/newsRead.php?no=881659Mon, 07 Jan 2019 10:15:00 +0900<![CDATA[GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment]]>https://www.newswire.co.kr/newsRead.php?no=862627Mon, 08 Jan 2018 16:55:00 +0900<![CDATA[Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery]]>https://www.newswire.co.kr/newsRead.php?no=851429Tue, 13 Jun 2017 11:55:00 +0900<![CDATA[키어런 머피, 존 플래너리에 이어 GE 헬스케어 CEO로 임명]]>https://www.newswire.co.kr/newsRead.php?no=851430Tue, 13 Jun 2017 11:55:00 +0900<![CDATA[Investing in Cures for Cancer: GE Poised to Lead Industrialization of Cell Therapy Industry with Acquisition of Biosafe Group SA]]>https://www.newswire.co.kr/newsRead.php?no=831058Thu, 14 Jul 2016 17:15:00 +0900<![CDATA[암치료 투자: GE, 바이오세이프 그룹 인수로 세포치료 산업화 주도]]>https://www.newswire.co.kr/newsRead.php?no=831059Thu, 14 Jul 2016 17:15:00 +0900<![CDATA[JHL Biotech Opens Innovative Biosimilars Manufacturing Facility in China]]>https://www.newswire.co.kr/newsRead.php?no=825617Wed, 11 May 2016 13:15:00 +0900<![CDATA[JHL 바이오테크, 중국에 혁신적인 바이오시밀러 제조시설 설립]]>https://www.newswire.co.kr/newsRead.php?no=825619Wed, 11 May 2016 13:15:00 +0900<![CDATA[GE Healthcare, FedDev Ontario Commit CAD $40M for New CCRM-Led Centre to Solve Cell Therapy Manufacturing Challenges]]>https://www.newswire.co.kr/newsRead.php?no=815084Wed, 13 Jan 2016 23:45:00 +0900<![CDATA[GE 헬스케어, 치료세포 제작 문제 해결 위해 CCRM이 주도하는 기술센터 건립에 FedDev 온타리오와 4000만 캐나다 달러 출연]]>https://www.newswire.co.kr/newsRead.php?no=815085Wed, 13 Jan 2016 23:45:00 +0900<![CDATA[CHMP Recommends EU Approval of VIZAMYL™ (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque]]>https://www.newswire.co.kr/newsRead.php?no=756801Tue, 01 Jul 2014 11:40:00 +0900